Article ID Journal Published Year Pages File Type
8236601 International Journal of Radiation Oncology*Biology*Physics 2009 8 Pages PDF
Abstract
Continuous infusion topotecan with RT was well tolerated and active in the treatment of poor-risk patients with unresectable Stage III NSCLC.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase II Trial of Combined Modality Therapy With Concurrent Topotecan Plus Radiotherapy Followed by Consolidation Chemotherapy for Unresectable Stage III and Selected Stage IV Non-Small-Lung Cancer
Authors
, , ,